Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 6, 1998, Pages 656-663

  Theocharis, S E ^a,b   Margeli, A P ^a   Agapitos, E V ^a   Mykoniatis, M G ^a   Kittas, C N ^a   Davaris, P S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Hepatic stimulator substance; Injury; Liver; Regeneration; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GROWTH FACTOR; HEPATIC STIMULATOR SUBSTANCE; THIOACETAMIDE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DNA SYNTHESIS; ENZYME ACTIVITY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER INJURY; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARCINOGENS; GROWTH SUBSTANCES; HEPATITIS, TOXIC; LIVER REGENERATION; MALE; MITOGENS; PEPTIDES; RATS; RATS, WISTAR; THIOACETAMIDE; TIME FACTORS;

EID: 0031862623     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171954     Document Type: Article

References (34)

1. Kirsch RE, Cohen CD, Saunders SJ, Van Hoorn-Hickman, Terblanche J, Alp M. Acute liver failure. In: Wright R, Millward-Sadler GH, Alberti KGMM, Karran S, editors. Liver and biliary disease. 3rd ed. London: Bailliere Tindall/WB Saunders; 1985, p. 659-76.
2. Fleig WE. Liver specific growth factors. Scand J Gastroenterol 1988;23 Suppl 151:31-6.
3. LaBrecque DR, Pesh LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975;248:273-84.
4. Fleig WE, Lehmann H, Wagner H, Hoss G, Ditschuneit H. Hepatic regenerative stimulator substance in the rabbit. Relation to liver regeneration after partial hepatectomy. J Hepatol 1986; 3:19-26.
5. Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J, et al. Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs. Cancer Res 1987;47:5600-5.
6. Mao-Hua M, Wei A, Bao-Hong Z, Qing S, De-Zheng G. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 1993; 17:638-44.
7. Zhiqiang Y, Weisong Y, Wenbin Z, Yong C, Yongxing Z. Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chin Med J 1992; 105:676-83.
8. Theocharis SE, Margeli AP, Spiliopoulou C, Skaltsas S, Kittas C, Koutselinis A. Hepatic stimulator substance administration enhances the regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectomized rats. Dig Dis Sci 1996;41: 1475-80.
9. Margeli A, Theocharis S, Spiliopoulou C, Horti M, Koutselinis A. Hepatic stimulator substance administration affects cadmium-induced hepatotoxicity in the rat. Int Hepatol Commun 1996;5:128-34.
10. Fitzhugh OG, Nelson AA. Liver tumors in rats fed thiourea or thioacetamide. Science 1948;108:626-8.
11. Trennery PN, Waring RH. Early changes in thioacetamide-induced liver damage. Toxicol Lett 1983;19:299-307.
12. Chanda S, Mehendale HM. Role of nutritional fatty acid and L-carnitine in the final outcome of thioacetamide hepatotoxicity. FASEB J 1994;8:1061-8.
13. Mangipudy RS, Chanda S, Mehendale HM. Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect 1995;103:260-7.
14. Reddy J, Chiga M, Svoboda D. Initiation of the division cycle of rat hepatocytes following a single injection of thioacetamide. Lab Invest 1969;20:405-11.
15. Munro HN, Fleck A. Recent developments in the measurement of nucleic acids in biological materials. Analyst 1966;91:78-88.
16. Richards GM. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 1974;57:369-76.
17. 2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 1988;112:232-9.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
19. International Federation of Clinical Chemistry: Committee on Standards, Enzyme Panel Clin Chem 1978;24:720-1.
20. LaBrecque DR, Feigenbaum A, Bachur NR. Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance. Science 1978;199:1082-4.
21. LaBrecque DR, Steele G, Fogerty S, Wilson M, Barton J. Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 1988;7:100-6.
22. LaBrecque DR, Bachur NR. Hepatic stimulator substance: physicochemical characteristics and specificity. Am J Physiol 1982;242:G281-8.
23. Higgins GM, Anderson RM. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-201.
24. Theocharis SE, Agapitos E, Margeli AP, Goutas N, Kittas C, Davaris P. Effect of two forms of granulocyte-colony-stimulating factor on hepatic regeneration after 70% partial hepatectomy in rats. Clin Sci 1997;92:315-20.
25. Porter WR, Gudzinowicz MJ, Neal RA. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide S-oxide in the rat. J Pharmacol Exp Ther 1979; 208:386-91.
26. Wei A, Mao-Hua M. A study of the protective mechanism of hepatic stimulator substance against experimental acute liver failure in mice. Acta Physiol Sinica 1992;44:54-61.
27. Fleig WE, Hoss G. Partial purification of rat stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 1989;9:240-8.
28. Zhiqiang Y, Weisong Y, Wenbin Z, Yong C, Fengyi Y. Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells. Hepatology 1990;12:1144-51.
29. Zhiqiang Y, Weisong Y, Benfu C, Peng S, Wenbin Z, Yong C. Purification and characterization of human hepatic stimulator substance. Chin Med J 1993;106:527-32.
30. Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng Q, Cillo U, et al. Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. Hepatology 1992;16:1267-70.
31. Francavilla A, Azzarone A, Carrieri G, Cillo U, Van Thiel D, Subbottin V, et al. Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology 1993;17:429-33.
32. Guillaume D, Clamon L, LaBrecque DR. Hepatic stimulator substance (HSS) stimulates phosphoinositol hydrolysis. Hepatology 1996;24(No 4, Pt.2) Suppl:362A.
33. Margeli A, Theocharis S, Skaltsas S, Skopelitou A, Kittas C, Mykoniatis M, et al. Effect of cadmium pretreatment on liver regeneration after partial hepatectomy in rats. Arch Toxicol 1994;68:85-90.
34. He F, Wu C, Tu Q, Xing G. Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue. Hepatology 1993;17:225-9.